Safety and effectiveness of oral propranolol for infantile hemangiomas started before 5 weeks and after 5 months of age: an Italian multicenter experience

• Prif Awduron: Maya El Hachem (Awdur), Francesco Gesualdo (Awdur), Andrea Diociaiuti (Awdur), Irene Berti (Awdur), Nadia Vercellino (Awdur), Valeria Boccaletti (Awdur), Iria Neri (Awdur), Giulio Porcedda (Awdur), Antonella Greco (Awdur), Claudia Carnevale (Awdur), Teresa Oranges (Awdur), Mario Cutrone (Awdur), Pietro Dalmonte (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: BMC, 2017-04-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Abstract Background Despite not being licensed for the treatment of infantile hemangiomas (IH) in infants younger than 5 weeks or older than 5 months, propranolol is often used in these age groups to prevent or to treat potentially severe complications. The objective of the present study was to revi...